Misoprostol use under routine conditions for termination of pregnancies with intrauterine fetal death
Autor(a) principal: | |
---|---|
Data de Publicação: | 2013 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Revista da Associação Médica Brasileira (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302013000400014 |
Resumo: | OBJECTIVE: To analyze the misoprostol use in pregnancies with intrauterine fetal death (IUFD), considering mode of delivery and induction-delivery interval. METHODS: Descriptive study including 171 pregnant women with IUFD, in the second or third trimester, submitted to labor induction with vaginal misoprostol and/or induction/augmentation with intravenous oxytocin, from 2005 to 2008, at a teaching-hospital of the Brazilian Unified Health System (Sistema Único de Saúde -SUS). RESULTS: Misoprostol alone (treatment A), misoprostol plus oxytocin (treatment B), and oxytocin alone (treatment C) were administered in 9.3%, 19.9%, and 70.8% of the cases, respectively. One-third of pregnancies were less than 28 weeks, and 2.9% required a caesarean section. The percentage of vaginal delivery in treatments A and B combined (98.0%) was similar to treatment C (96.7%). The mean induction-delivery interval was 15.4 hours. Comparing multiple groups, the mean induction-delivery interval was significantly shorter in treatment A (20.1 hours) than in treatment B (33.3 hours), and was longer than in treatment C (9.7 hours). The majority (71%) of cases required a single administration of misoprostol, and the total dosage was lower in treatment A (mean: 98.4 µg) compared with treatment B (mean: 157.0 µg). CONCLUSION: Misoprostol effectively contributed to delivery of IUFD by vaginal route assisted under routine conditions of a public health service in Brazil, demonstrating its importance in cases resistant to usual induction methods, and its availability in Brazilian public health services is recommended. |
id |
AMB-1_52816635c099ef312cef82ad99197d88 |
---|---|
oai_identifier_str |
oai:scielo:S0104-42302013000400014 |
network_acronym_str |
AMB-1 |
network_name_str |
Revista da Associação Médica Brasileira (Online) |
repository_id_str |
|
spelling |
Misoprostol use under routine conditions for termination of pregnancies with intrauterine fetal deathMisoprostolOxytocinLabor inducedDelivery obstetricFetal deathStillbirthOBJECTIVE: To analyze the misoprostol use in pregnancies with intrauterine fetal death (IUFD), considering mode of delivery and induction-delivery interval. METHODS: Descriptive study including 171 pregnant women with IUFD, in the second or third trimester, submitted to labor induction with vaginal misoprostol and/or induction/augmentation with intravenous oxytocin, from 2005 to 2008, at a teaching-hospital of the Brazilian Unified Health System (Sistema Único de Saúde -SUS). RESULTS: Misoprostol alone (treatment A), misoprostol plus oxytocin (treatment B), and oxytocin alone (treatment C) were administered in 9.3%, 19.9%, and 70.8% of the cases, respectively. One-third of pregnancies were less than 28 weeks, and 2.9% required a caesarean section. The percentage of vaginal delivery in treatments A and B combined (98.0%) was similar to treatment C (96.7%). The mean induction-delivery interval was 15.4 hours. Comparing multiple groups, the mean induction-delivery interval was significantly shorter in treatment A (20.1 hours) than in treatment B (33.3 hours), and was longer than in treatment C (9.7 hours). The majority (71%) of cases required a single administration of misoprostol, and the total dosage was lower in treatment A (mean: 98.4 µg) compared with treatment B (mean: 157.0 µg). CONCLUSION: Misoprostol effectively contributed to delivery of IUFD by vaginal route assisted under routine conditions of a public health service in Brazil, demonstrating its importance in cases resistant to usual induction methods, and its availability in Brazilian public health services is recommended.Associação Médica Brasileira2013-08-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302013000400014Revista da Associação Médica Brasileira v.59 n.4 2013reponame:Revista da Associação Médica Brasileira (Online)instname:Associação Médica Brasileira (AMB)instacron:AMB10.1016/j.ramb.2013.02.005info:eu-repo/semantics/openAccessNascimento,Maria Isabel doCunha,Alfredo de AlmeidaOliveira,Sandra Regina dos Santos MuriNunes,Glaucimara GonzagaAlvarez,Felipe SilvaVillas Bôas,Eduardo Loyolaeng2015-07-28T00:00:00Zoai:scielo:S0104-42302013000400014Revistahttps://ramb.amb.org.br/ultimas-edicoes/#https://old.scielo.br/oai/scielo-oai.php||ramb@amb.org.br1806-92820104-4230opendoar:2015-07-28T00:00Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB)false |
dc.title.none.fl_str_mv |
Misoprostol use under routine conditions for termination of pregnancies with intrauterine fetal death |
title |
Misoprostol use under routine conditions for termination of pregnancies with intrauterine fetal death |
spellingShingle |
Misoprostol use under routine conditions for termination of pregnancies with intrauterine fetal death Nascimento,Maria Isabel do Misoprostol Oxytocin Labor induced Delivery obstetric Fetal death Stillbirth |
title_short |
Misoprostol use under routine conditions for termination of pregnancies with intrauterine fetal death |
title_full |
Misoprostol use under routine conditions for termination of pregnancies with intrauterine fetal death |
title_fullStr |
Misoprostol use under routine conditions for termination of pregnancies with intrauterine fetal death |
title_full_unstemmed |
Misoprostol use under routine conditions for termination of pregnancies with intrauterine fetal death |
title_sort |
Misoprostol use under routine conditions for termination of pregnancies with intrauterine fetal death |
author |
Nascimento,Maria Isabel do |
author_facet |
Nascimento,Maria Isabel do Cunha,Alfredo de Almeida Oliveira,Sandra Regina dos Santos Muri Nunes,Glaucimara Gonzaga Alvarez,Felipe Silva Villas Bôas,Eduardo Loyola |
author_role |
author |
author2 |
Cunha,Alfredo de Almeida Oliveira,Sandra Regina dos Santos Muri Nunes,Glaucimara Gonzaga Alvarez,Felipe Silva Villas Bôas,Eduardo Loyola |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Nascimento,Maria Isabel do Cunha,Alfredo de Almeida Oliveira,Sandra Regina dos Santos Muri Nunes,Glaucimara Gonzaga Alvarez,Felipe Silva Villas Bôas,Eduardo Loyola |
dc.subject.por.fl_str_mv |
Misoprostol Oxytocin Labor induced Delivery obstetric Fetal death Stillbirth |
topic |
Misoprostol Oxytocin Labor induced Delivery obstetric Fetal death Stillbirth |
description |
OBJECTIVE: To analyze the misoprostol use in pregnancies with intrauterine fetal death (IUFD), considering mode of delivery and induction-delivery interval. METHODS: Descriptive study including 171 pregnant women with IUFD, in the second or third trimester, submitted to labor induction with vaginal misoprostol and/or induction/augmentation with intravenous oxytocin, from 2005 to 2008, at a teaching-hospital of the Brazilian Unified Health System (Sistema Único de Saúde -SUS). RESULTS: Misoprostol alone (treatment A), misoprostol plus oxytocin (treatment B), and oxytocin alone (treatment C) were administered in 9.3%, 19.9%, and 70.8% of the cases, respectively. One-third of pregnancies were less than 28 weeks, and 2.9% required a caesarean section. The percentage of vaginal delivery in treatments A and B combined (98.0%) was similar to treatment C (96.7%). The mean induction-delivery interval was 15.4 hours. Comparing multiple groups, the mean induction-delivery interval was significantly shorter in treatment A (20.1 hours) than in treatment B (33.3 hours), and was longer than in treatment C (9.7 hours). The majority (71%) of cases required a single administration of misoprostol, and the total dosage was lower in treatment A (mean: 98.4 µg) compared with treatment B (mean: 157.0 µg). CONCLUSION: Misoprostol effectively contributed to delivery of IUFD by vaginal route assisted under routine conditions of a public health service in Brazil, demonstrating its importance in cases resistant to usual induction methods, and its availability in Brazilian public health services is recommended. |
publishDate |
2013 |
dc.date.none.fl_str_mv |
2013-08-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302013000400014 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302013000400014 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1016/j.ramb.2013.02.005 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Associação Médica Brasileira |
publisher.none.fl_str_mv |
Associação Médica Brasileira |
dc.source.none.fl_str_mv |
Revista da Associação Médica Brasileira v.59 n.4 2013 reponame:Revista da Associação Médica Brasileira (Online) instname:Associação Médica Brasileira (AMB) instacron:AMB |
instname_str |
Associação Médica Brasileira (AMB) |
instacron_str |
AMB |
institution |
AMB |
reponame_str |
Revista da Associação Médica Brasileira (Online) |
collection |
Revista da Associação Médica Brasileira (Online) |
repository.name.fl_str_mv |
Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB) |
repository.mail.fl_str_mv |
||ramb@amb.org.br |
_version_ |
1754212830761975808 |